دورية أكاديمية

Epithelial ovarian tumors: Clinicopathological correlation and immunohistochemical study

التفاصيل البيبلوغرافية
العنوان: Epithelial ovarian tumors: Clinicopathological correlation and immunohistochemical study
المؤلفون: Pooja S Naik, Sanjay Deshmukh, Siddhi Gaurish Sinai Khandeparkar, Avinash Joshi, Shridhar Babanagare, Jyostna Potdar, Neelesh Sharad Risbud
المصدر: Journal of Mid-Life Health, Vol 6, Iss 4, Pp 178-183 (2015)
بيانات النشر: Wolters Kluwer Medknow Publications
سنة النشر: 2015
المجموعة: Directory of Open Access Journals: DOAJ Articles
مصطلحات موضوعية: Estrogen receptors, immunohistochemical, Ki-67, p53, progesterone receptors, surface epithelial ovarian tumors, Gynecology and obstetrics, RG1-991, Geriatrics, RC952-954.6
الوصف: Background: Ovarian cancer is the third leading site of cancer among women, trailing behind cervix and breast cancer. Aim: This study was undertaken to analyze the immunohistochemical (IHC) profile of estrogen receptors (ER), progesterone receptors (PR), Ki-67, and p53 in various ovarian epithelial tumors and attempt correlation with clinical and histopathological findings. Materials and Methods: The present study was conducted over a period of 4 years. A technique of manual tissue array was employed for cases subjected for IHC. The primary antibodies used were ER, PR, p53, and Ki-67. A correlation was attempted between histopathological and IHC findings. Results were subjected to statistical analysis. Software program "the primer of biostatistics 5.0" was used for calculation of interrelationships between the analyzed ER, PR, p53, and Ki-67 expression and histological factors by Pearson′s Chi-square test. The results were considered to be significant when the P < 0.05. Results: There were 110 cases of surface epithelial ovarian tumors (SEOT) encountered over the period of 4 years. The expression of ER was more in malignant tumors (13/16, 81.25%) than borderline (9/12, 75%) and benign (20/82, 24.39%). As compared to ER, the expression of PR was more in benign (51/82, 62.19%) than borderline (8/12, 66.67%) and malignant tumors (9/16, 56.25%). The expression of PR was more in benign tumors than borderline and malignant tumors. However, this was not statistically significant (Chi-square = 0.335 with 2 degrees of freedom; P = 0.846). The expression of p53 was less in benign (5/82, 6.1%) than borderline (9/12, 75%) and malignant tumors (13/16, 81.25%). The expression of Ki-67 was more in malignant (4/82, 4.88%) than borderline (10/12, 83.33%) and benign tumors (15/16, 93.75%). In all the above cases, the difference was statistically significant (P < 0.05). There was statistically significant difference in the expression of ER, PR, p53, and Ki-67 in the patients with age <40 years and above 40 years (P = ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0976-7800
0976-7819
العلاقة: http://www.jmidlifehealth.org/article.asp?issn=0976-7800;year=2015;volume=6;issue=4;spage=178;epage=183;aulast=NaikTest; https://doaj.org/toc/0976-7800Test; https://doaj.org/toc/0976-7819Test; https://doaj.org/article/be940457bfee4613ab4a921d3009df8fTest
DOI: 10.4103/0976-7800.172349
الإتاحة: https://doi.org/10.4103/0976-7800.172349Test
https://doaj.org/article/be940457bfee4613ab4a921d3009df8fTest
رقم الانضمام: edsbas.E21007CC
قاعدة البيانات: BASE
الوصف
تدمد:09767800
09767819
DOI:10.4103/0976-7800.172349